HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Dividend Yield

The Dividend Yield of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is 1.45 %. In the previous year, Dividend Yield was 1.96 % — a change of -26.32% (lower).

Dividend Yield

1.45 %

YoY

-26.32%

Last updated:

Dividend Yield of HaTay Pharmaceutical JSC is 2024 1.45 % . Dividend Yield of HaTay Pharmaceutical JSC was 2023 1.96 % . It decreases by -26.32% lower compared to the previous year.

The HaTay Pharmaceutical JSC Dividend Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Yield
Date
Dividend Yield
Jan 1, 2015
1.31 VND
Jan 1, 2016
1.31 VND
Jan 1, 2017
0.88 VND
Jan 1, 2018
3.50 VND
Jan 1, 2019
2.89 VND
Jan 1, 2020
2.89 VND
Jan 1, 2022
1.96 VND
Jan 1, 2024
1.45 VND
The HaTay Pharmaceutical JSC Dividend Yield history
YEARDividend YieldYoY
1.45 %-26.32%
1.96 %-32.14%
2.89 %0.00%
2.89 %-17.50%
3.50 %+300.00%
0.88 %-33.33%
1.31 %0.00%
1.31 %-25.00%
1.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Dividend Yield of HaTay Pharmaceutical JSC is 1.45 % in 2024.

Dividend Yield of HaTay Pharmaceutical JSC changed from 1.96 % to 1.45 %, representing a -26.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Yield HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's HaTay Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — HaTay Pharmaceutical JSC

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — HaTay Pharmaceutical JSC